Skip to main content

Table 1 The clinical characteristics of COAD patients

From: Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma

Characteristics

Samples

Percent (%)

Gender

Female

179

45.3

Male

216

54.7

Age

 ≤ 60y

119

30.1

 > 60y

276

69.9

Clinical stages

Stage I

67

17

Stage II

153

38.7

Stage III

113

28.6

Stage IV

51

12.9

Unknown

11

2.8

T stages

T0/Tis

1

0.3

T1

9

2.3

T2

68

17.2

T3

269

68.1

T4

48

12.2

N stages

N0

233

59

N1

95

24

N2

67

17

M stages

M0

297

75.2

M1

51

12.9

Unknown

47

11.9

Survival status

Alive

323

81.8

Dead

72

18.2

Treatment or therapy

Yes

67

17

No

296

74.9

Unknown

32

8.1